C3 glomerulonephritis
C3 Glomerulonephritis (C3GN) is a rare kidney disease characterized by the accumulation of C3 proteins in the glomeruli due to abnormal regulation of the complement system. This disease is part of a broader category of diseases known as C3 glomerulopathy.
Etiology[edit | edit source]
The exact cause of C3GN is not fully understood. However, it is believed to be associated with genetic mutations that affect the regulation of the complement system, a part of the immune system that helps to fight off infections. These mutations can lead to uncontrolled activation of the complement system, resulting in damage to the glomeruli.
Symptoms[edit | edit source]
The symptoms of C3GN can vary widely, but often include proteinuria, hematuria, and hypertension. In severe cases, it can lead to kidney failure, requiring dialysis or a kidney transplant.
Diagnosis[edit | edit source]
Diagnosis of C3GN is typically made through a kidney biopsy, which allows for the examination of the kidney tissue under a microscope. The presence of C3 proteins in the glomeruli, without significant amounts of other immune proteins, is indicative of C3GN.
Treatment[edit | edit source]
There is currently no specific treatment for C3GN. Management of the disease typically involves controlling the symptoms and slowing the progression of kidney damage. This may include medications to control blood pressure and reduce proteinuria, as well as immunosuppressive drugs in some cases.
Prognosis[edit | edit source]
The prognosis for individuals with C3GN can vary widely, depending on the severity of the disease and the individual's response to treatment. Some individuals may experience a slow progression of the disease over many years, while others may experience rapid progression to kidney failure.
See also[edit | edit source]
This <a href="/wiki/Rare_disease" title="Rare disease">rare disease</a>-related article is a <a href="/wiki/Stub" title="Stub">stub</a>. You can help <a href="/wiki/WikiMD" title="WikiMD">WikiMD</a> by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD